Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 7, 2023

video: Emotional aspects of growing older while living with Multiple Sclerosis

  • Mental Health
    /
  • MS Educational Programs
    /
  • Multiple Sclerosis
    /
  Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Visit our MS Learning Channel on YouTube:…
Mental Health

April 7, 2023

Speed-based cognitive exercises may reduce likelihood of falls in high-risk older adults

  • Misc. MS Related
    /
 Key takeaways: Participants at high risk for future falls were 31% less likely to experience falls over 10 years after…
Misc. MS Related

April 6, 2023

How MS Affects Your Brain

  • Multiple Sclerosis
    /
 Multiple sclerosis (MS) is an unpredictable and long lasting disease of the central nervous system that disrupts communication between the…
Multiple Sclerosis

April 3, 2023

video: Sexual Health and Multiple Sclerosis: From Frustration to Fulfillment

  • Boster's MS Corner
    /
 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education  Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Boster's MS Corner

April 2, 2023

WATCH An inspiring documentary that explores the impact of MS, in Black and African American communities

  • Health Equity
    /
  • Inspirational
    /
  • Multiple Sclerosis
    /
 2023 – An inspiring documentary that explores the impact of MS in Black and African American communities, from Medical Stories, the award-winning docuseries,…
Health Equity

March 27, 2023

Not directly related to MS, but can be for many with MS : Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation

  • Misc. MS Related
    /
Mar 21, 2023Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®* With this approval, Sandoz…
Misc. MS Related

March 25, 2023

Interesting read: Learn about one of the newest MS medications – Tascenso-ODT (fingolimod)

  • MS Drug Therapies
    /
  To learn about Tascenso-ODT which was just approved in February 2023,  click here Information provided by: Visit our MS…
MS Drug Therapies

March 25, 2023

Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study…
MS Drug Therapies

March 25, 2023

With multiple sclerosis, it’s hard to stop saying ‘I’m sorry,’ but you should — (Stus Views: This is a fabulous Article that should be read by many) —

  • An MS Patients Story
    /
 (Stuart’s Thanks to Benjamin for writing the story showing below, which is needed to be read by many who should…
An MS Patients Story

March 25, 2023

Primary progressive MS confirmed as own disorder in mouse study

  • MS Research Study and Reports
    /
  • SPMS-PPMS News
    /
 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS by Marisa Wexler, MS | February 7, 2023…
MS Research Study and Reports

Categories

Latest Blog Posts